TAMOXIFEN ELEVATES TRANSFORMING GROWTH-FACTOR-BETA AND SUPPRESSES DIET-INDUCED FORMATION OF LIPID LESIONS IN MOUSE AORTA

被引:124
作者
GRAINGER, DJ
WITCHELL, CM
METCALFE, JC
机构
[1] Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, Tennis Court Road
关键词
D O I
10.1038/nm1095-1067
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
When C57B16 male mice are fed a high-fat diet, they develop significant fatty streak lesions in the aorta. Addition of tamoxifen (TMX) to a high-fat diet, equivalent to a dose of approximately 1 mg TMX per kg body weight per day, suppressed the diet-induced increase in the area of lipid staining in the aortic sinus of the mice by 88% and in the average number of lesions by 86%. The TMX-treated mice had 11% +/- 5% less total plasma cholesterol, with most of the reduction in the high density lipoprotein fraction, whereas plasma triglycerides were significantly elevated, and circulating concentrations of 17 beta-estradiol and testosterone were unaffected. Both circulating and aortic concentrations of active and latent transforming growth factor-beta (TGF-beta) were substantially elevated by TMX. The inhibition of lesion formation may be due, at least in part, to cardiovascular protection by TGF-beta.
引用
收藏
页码:1067 / 1073
页数:7
相关论文
共 40 条
  • [1] ALLAIN CC, 1974, CLIN CHEM, V20, P470
  • [2] ADJUVANT TAMOXIFEN IN PRIMARY BREAST-CANCER - INFLUENCE ON PLASMA-LIPIDS AND ANTITHROMBIN-III LEVELS
    BERTELLI, G
    PRONZATO, P
    AMOROSO, D
    CUSIMANO, MP
    CONTE, PF
    MONTAGNA, G
    BERTOLINI, S
    ROSSO, R
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (03) : 307 - 310
  • [3] BUTTA A, 1992, CANCER RES, V52, P4261
  • [4] EFFECT OF TAMOXIFEN ON ESTROGEN BINDING, LIPID AND LIPOPROTEIN CONCENTRATIONS AND BLOOD-CLOTTING PARAMETERS IN PREMENOPAUSAL WOMEN WITH BREAST PAIN
    CALEFFI, M
    FENTIMAN, IS
    CLARK, GM
    WANG, DY
    NEEDHAM, J
    CLARK, K
    LAVILLE, A
    LEWIS, B
    [J]. JOURNAL OF ENDOCRINOLOGY, 1988, 119 (02) : 335 - 339
  • [5] THE GROWTH-INHIBITION OF HUMAN BREAST-CANCER CELLS BY A NOVEL SYNTHETIC PROGESTIN INVOLVES THE INDUCTION OF TRANSFORMING GROWTH-FACTOR-BETA
    COLLETTA, AA
    WAKEFIELD, LM
    HOWELL, FV
    DANIELPOUR, D
    BAUM, M
    SPORN, MB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (01) : 277 - 283
  • [6] ANTIESTROGENS INDUCE THE SECRETION OF ACTIVE TRANSFORMING GROWTH-FACTOR-BETA FROM HUMAN FETAL FIBROBLASTS
    COLLETTA, AA
    WAKEFIELD, LM
    HOWELL, FV
    VANROOZENDAAL, KEP
    DANIELPOUR, D
    EBBS, SR
    SPORN, MB
    BAUM, M
    [J]. BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 405 - 409
  • [7] EMESON EE, 1993, AM J PATHOL, V142, P1906
  • [8] THE PHARMACOLOGY AND CLINICAL USES OF TAMOXIFEN
    FURR, BJA
    JORDAN, VC
    [J]. PHARMACOLOGY & THERAPEUTICS, 1984, 25 (02) : 127 - 205
  • [9] MOLECULAR-CLONING AND CHARACTERIZATION OF 2B7, A RAT MESSENGER-RNA WHICH DISTINGUISHES SMOOTH-MUSCLE CELL PHENOTYPES INVITRO AND IS IDENTICAL TO OSTEOPONTIN (SECRETED PHOSPHOPROTEIN-I, 2AR)
    GIACHELLI, C
    BAE, N
    LOMBARDI, D
    MAJESKY, M
    SCHWARTZ, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (02) : 867 - 873
  • [10] OSTEOPONTIN IS ELEVATED DURING NEOINTIMA FORMATION IN RAT ARTERIES AND IS A NOVEL COMPONENT OF HUMAN ATHEROSCLEROTIC PLAQUES
    GIACHELLI, CM
    BAE, N
    ALMEIDA, M
    DENHARDT, DT
    ALPERS, CE
    SCHWARTZ, SM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) : 1686 - 1696